Journal of Applied Physiology Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 99: 344-348, 2005. First published February 10, 2005; doi:10.1152/japplphysiol.00037.2005
8750-7587/05 $8.00
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
99/1/344    most recent
00037.2005v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lucia, A.
Right arrow Articles by Franks, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lucia, A.
Right arrow Articles by Franks, P. W.

HIGHLIGHTED TOPICS
Role of Exercise in Reducing the Risk of Diabetes and Obesity

PPARGC1A genotype (Gly482Ser) predicts exceptional endurance capacity in European men

Alejandro Lucia,1 Félix Gómez-Gallego,2 Inês Barroso,3 Manuel Rabadán,4 Fernando Bandrés,1 Alejandro F. San Juan,1 José L. Chicharro,5 Ulf Ekelund,6 Soren Brage,6 Conrad P. Earnest,7 Nicholas J. Wareham,6 and Paul W. Franks8

1European University of Madrid, Madrid, Spain; 2Department of Toxicology, Complutense University, Madrid, Spain; 3The Wellcome Trust Sanger Institute, Metabolic Disease Group, Cambridge, United Kingdom; 4Department of Sports Medicine, Higher Sports Council, Madrid, Spain; 5School of Nursing, Complutense University, Madrid, Spain; 6Medical Research Center Epidemiology Unit, Cambridge, United Kingdom; 7The Cooper Institute Center for Human Performance and Nutrition Research, Dallas, Texas; and 8Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona

Submitted 11 January 2005 ; accepted in final form 6 February 2005

Animal and human data indicate a role for the peroxisome proliferator-activated receptor-{gamma} coactivator 1{alpha} (PPARGC1A) gene product in the development of maximal oxygen uptake (O2 max), a determinant of endurance capacity, diabetes, and early death. We tested the hypothesis that the frequency of the minor Ser482 allele at the PPARGC1A locus is lower in World-class Spanish male endurance athletes (cases) [n = 104; mean (SD) age: 26.8 (3.8) yr] than in unfit United Kingdom (UK) Caucasian male controls [n = 100; mean (SD) age: 49.3 (8.1) yr]. In cases and controls, the Gly482Ser genotype met Hardy-Weinberg expectations (P > 0.05 in both groups tested separately). Cases had significantly higher O2 max [73.4 (5.7) vs. 29.4 ml·kg–1·min–1 (3.8); P < 0.0001] and were leaner [body mass index: 20.6 (1.5) vs. 27.6 kg/m2 (3.9); P < 0.0001] than controls. In unadjusted {chi}2 analyses, the frequency of the minor Ser482 allele was significantly lower in cases than in controls (29.1 vs. 40.0%; P = 0.01). To assess the possibility that genetic stratification could confound these observations, we also compared Gly482Ser genotype frequencies in Spanish (n = 164) and UK Caucasian men (n = 381) who were unselected for their level of fitness. In these analyses, Ser482 allele frequencies were very similar (36.9% in Spanish vs. 37.5% in UK Caucasians, P = 0.83), suggesting that confounding by genetic stratification is unlikely to explain the association between Gly482Ser genotype and endurance capacity. In summary, our data indicate a role for the Gly482Ser genotype in determining aerobic fitness. This finding has relevance from the perspective of physical performance, but it may also be informative for the targeted prevention of diseases associated with low fitness such as Type 2 diabetes.

single nucleotide polymorphism; maximal oxygen uptake; metabolism; genetics; diabetes



Address for reprint requests and other correspondence: P. Franks, Phoenix Epidemiology & Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, 1550 E. Indian School Rd., Phoenix, AZ 85014 (E-mail: pfranks{at}niddk.nih.gov)




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
N. Eynon, M. Sagiv, Y. Meckel, J. A. Duarte, A. J. Alves, C. Yamin, M. Sagiv, E. Goldhammer, and J. Oliveira
NRF2 intron 3 A/G polymorphism is associated with endurance athletes' status
J Appl Physiol, July 1, 2009; 107(1): 76 - 79.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. Kacerovsky-Bielesz, M. Chmelik, C. Ling, R. Pokan, J. Szendroedi, M. Farukuoye, M. Kacerovsky, A. I. Schmid, S. Gruber, M. Wolzt, et al.
Short-Term Exercise Training Does Not Stimulate Skeletal Muscle ATP Synthesis in Relatives of Humans With Type 2 Diabetes
Diabetes, June 1, 2009; 58(6): 1333 - 1341.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Sports. Med.Home page
M Gonzalez-Freire, C Santiago, Z Verde, J I Lao, J OIivan, F Gomez-Gallego, and A Lucia
Unique among unique. Is it genetically determined?
Br. J. Sports Med., April 1, 2009; 43(4): 307 - 309.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. R. Ruiz, F. Gomez-Gallego, C. Santiago, M. Gonzalez-Freire, Z. Verde, C. Foster, and A. Lucia
Is there an optimum endurance polygenic profile?
J. Physiol., April 1, 2009; 587(7): 1527 - 1534.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
N. Eynon, J. Oliveira, Y. Meckel, M. Sagiv, C. Yamin, M. Sagiv, R. Amir, and J. A. Duarte
The guanine nucleotide binding protein {beta} polypeptide 3 gene C825T polymorphism is associated with elite endurance athletes
Exp Physiol, March 1, 2009; 94(3): 344 - 349.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
K. S. Vimaleswaran, J. Luan, G. Andersen, Y. L. Muller, E. Wheeler, E. C. Brito, S. O'Rahilly, O. Pedersen, L. J. Baier, W. C. Knowler, et al.
The Gly482Ser genotype at the PPARGC1A gene and elevated blood pressure: a meta-analysis involving 13,949 individuals
J Appl Physiol, October 1, 2008; 105(4): 1352 - 1358.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. G. Williams and J. P. Folland
Similarity of polygenic profiles limits the potential for elite human physical performance
J. Physiol., January 1, 2008; 586(1): 113 - 121.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. Brage, U. Ekelund, N. Brage, M. A. Hennings, K. Froberg, P. W. Franks, and N. J. Wareham
Hierarchy of individual calibration levels for heart rate and accelerometry to measure physical activity
J Appl Physiol, August 1, 2007; 103(2): 682 - 692.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Stefan, C. Thamer, H. Staiger, F. Machicao, J. Machann, F. Schick, C. Venter, A. Niess, M. Laakso, A. Fritsche, et al.
Genetic Variations in PPARD and PPARGC1A Determine Mitochondrial Function and Change in Aerobic Physical Fitness and Insulin Sensitivity during Lifestyle Intervention
J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1827 - 1833.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.